Aurora Cannabis (TSE:ACB) Posts Earnings Results

Aurora Cannabis (TSE:ACB) released its quarterly earnings results on Wednesday. The company reported C($0.07) EPS for the quarter, FiscalAI reports. The firm had revenue of C$67.55 million for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%.

Aurora Cannabis Stock Performance

TSE ACB opened at C$4.17 on Friday. The company has a debt-to-equity ratio of 4.66, a quick ratio of 2.48 and a current ratio of 5.94. The firm has a market cap of C$258.30 million, a price-to-earnings ratio of -1.95 and a beta of 0.25. The firm has a 50 day simple moving average of C$4.10 and a 200-day simple moving average of C$4.64. Aurora Cannabis has a one year low of C$3.59 and a one year high of C$9.33.

Wall Street Analyst Weigh In

ACB has been the subject of a number of research analyst reports. TD lowered their price target on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a report on Friday, June 12th. Canaccord Genuity Group reduced their price objective on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of C$7.17.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.